Supplemental material
Open access
3,017
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Population pharmacokinetics of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderately to severely active rheumatoid arthritis
Rameshraja PalaparthyClinical
Pharmacology, Pfizer
Inc, San Diego,
CA, USACorrespondence[email protected]
View further author information
, View further author information
Muhammad I. RehmanClinical
Development, Pfizer
Inc, Andover, MA,
USAView further author information
, Oliver von RichterGlobal Clinical Development,
Biopharmaceuticals, Sandoz Biopharmaceuticals, Hexal AG
(a Sandoz company), Holzkirchen,
GermanyView further author information
& Donghua YinClinical
Pharmacology, Pfizer
Inc, San Diego,
CA, USAView further author information
Pages 1065-1074
|
Received 12 Feb 2019, Accepted 20 Jun 2019, Published online: 08 Jul 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.